CGT-1881

N/A

Report date: 2023/02/15 20:00:47
NME

Base Information

Drug NameCGT-1881
Drug Alias NameCGT-1881CGT1881
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-X-C motif chemokine receptor 4 antagonists
TargetsC-X-C motif chemokine receptor 4
Therapy Area/IndicationsHematologic NeoplasmsMultiple MyelomaLymphoma, Non-Hodgkin +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesCgenetech(Suzhou China) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesCgenetech(Suzhou China) Co Ltd
Inactive CompaniesN/A
Active IndicationsHematologic NeoplasmsMultiple MyelomaLymphoma, Non-Hodgkin +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A